| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.9B | $19.9B | $19.1B | $15.9B | $14.3B | $3.2B | $3.7B | $3.8B |
| Cost of Revenue | $12.5B | $12.8B | $12.6B | $11.4B | $10.4B | $10.3B | $10.7B | $10.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.2B | $0.3B | $0.3B | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B |
| SG&A Expense | $3.3B | $3.3B | $3.4B | $1.6B | $1.5B | $1.7B | $1.5B | $1.7B |
| Operating Income | $4.3B | $4.1B | $3.4B | $3.0B | $2.5B | $2.0B | $2.4B | $2.2B |
| Net Income | $3.5B | $2.8B | $2.1B | $1.3B | $1.7B | $0.3B | $0.4B | $0.4B |
| EPS (Basic) | $27.52 | $22.13 | $16.23 | $10.24 | $13.54 | $9.39 | $11.63 | $7.98 |
| EPS (Diluted) | $27.12 | $21.84 | $16.04 | $10.09 | $13.35 | $2.27 | $3.17 | $2.62 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.5B | $29.3B | $30.0B | $25.9B | $20.3B | $19.7B | $17.6B | $15.3B |
| Current Assets | $7.0B | $6.8B | $6.8B | $12.0B | $5.6B | $4.9B | $7.7B | $5.1B |
| Cash & Equivalents | $0.5B | $0.4B | $0.5B | $0.5B | $0.7B | $0.7B | $3.2B | $0.8B |
| Total Liabilities | $15.8B | $17.2B | $19.6B | $17.1B | $11.9B | $13.6B | $11.6B | $9.5B |
| Current Liabilities | $5.8B | $7.3B | $7.7B | $5.9B | $3.1B | $3.1B | $3.2B | $3.2B |
| Stockholders' Equity | $13.7B | $12.1B | $10.3B | $8.8B | $8.4B | $6.1B | $6.0B | $5.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.8B | $3.4B | $3.0B | $2.4B | $2.6B | $2.1B | $1.7B | $1.6B |
| Investing Cash Flow | $0.2B | $-0.3B | $-8.2B | $-0.4B | $-0.0B | $-5.0B | $-0.2B | $0.0B |
| Capital Expenditures | $0.4B | $0.4B | $0.4B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-4.0B | $-3.1B | $-1.0B | $3.9B | $-2.6B | $0.4B | $0.9B | $-1.7B |